Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Treatment Protocol for the Use of the Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions

NCT04172922 is registered in ClinicalTrials.gov with Nemours Children's Clinic as lead sponsor.

NCT NCT04172922
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04172922 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Treatment Protocol for the Use of the Topical Rapamycin/Sirolimus for Complicated Vascular Anomalies and Other Susceptible Lesions
Lead sponsor
Nemours Children's Clinic
Phase
Phase 1
Overall status
Terminated
Start date
April 1, 2020
Completion date
February 15, 2024
Enrollment
5 (actual)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

vascular anomaly